Skip to content
To simplify and streamline the COVID-19 vaccination process while pushing for increased vaccination rates, the U.S. Food and Drug Administration (FDA) proposed updating the […]
FDA proposes updating COVID boosters annually Read More »
Rachel King, Interim CEO of the Biotechnology Innovation Organization (BIO), described the organization’s work and goals for 2023 at the Maryland Tech Council (MTC)’s
BIO’s Interim CEO discusses biotech policy, optimism with industry in Maryland Read More »
The U.S. Patent and Trademark Office (USPTO) and the U.S. Food and Drug Administration (FDA) convened a joint session on drug patent systems yesterday.
Patent systems for drugs matter – here’s why Read More »
When the largest private insurance companies use their leverage to save on the cost of prescription drugs, they make it harder for patients to
Excluding drugs from coverage helps PBMs keep profits higher Read More »
Moderna is edging closer to launching a new investigational mRNA vaccine to fight the respiratory syncytial virus (RSV), which was 83.7% effective at preventing
Moderna RSV vaccine is 83.7% effective in Phase 3 trial Read More »
A new partnership will use biotechnology to bring baby formula closer to mothers’ milk, Good Day BIO reports. Ginkgo Bioworks announced yesterday it’s partnering
Ginkgo Bioworks will use biotech to boost baby formula’s gut-health properties Read More »
Pfizer Inc. announced on Tuesday it is expanding its initiative focused on reducing health inequities in many lower-income countries by offering “the full portfolio
Pfizer expands access to full drug portfolio worldwide Read More »
The cost of innovative gene therapies to treat and eradicate sickle cell disease (SCD) is far lower than the lifetime medical expenses of having
The true cost of sickle cell disease treatment Read More »
Kindergarten vaccination rates have dropped dramatically since the start of the COVID-19 pandemic, and experts say it’s due to vaccine hesitancy. The 2019–2020 school
Kindergarten vaccination rates fall due to vaccine hesitancy Read More »
The biotechnology industry is one of the riskiest and the most challenging—but it is also one of the few that makes the difference between
2022 was a challenging year for biotechnology. What’s in store for 2023? Read More »
